Antipsychotic-induced akathisia in delirium: A systematic review

Palliative and Supportive Care

Volumn 14, Issue 1, 2016, Pages 77-84

  Espi Forcen, Fernando ^a   Matsoukas, Konstantina ^a   Alici, Yesne ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Akathisia; Antipsychotics; Delirium

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE;

AKATHISIA; COMPLICATION; DELIRIUM; HUMAN; PREVALENCE;

AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; DELIRIUM; HALOPERIDOL; HUMANS; PREVALENCE; RISPERIDONE;

EID: 84958038519     PISSN: 14789515     EISSN: 14789523     Source Type: Journal    
DOI: 10.1017/s1478951515000784     Document Type: Review

References (41)

1. American Psychiatric Association (APA) (2013). Diagnostic and statistical manual of mental disorders, 5th ed. [DSM-V]. Arlington, VA: American Psychiatric Publishing.
2. Barnes, T. &Braude, W. (1985). Akathisia variants and tardive dyskinesia. Archives of General Psychiatry, 42(9), 874-878.
3. Berrios, G. E. (1995). Lad Haskovec and akathisia. History of Psychiatry, 6(22, Pt. 2), 243-251.
4. Breitbart, W. & Alici, Y. (2012). Evidence-based treatment of delirium in patients with cancer. Journal of Clinical Oncology, 30(11), 1206-1214.
5. Breitbart, W., Marotta, R., Platt, M. M., et al. (1996). A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. The American Journal of Psychiatry, 153(2), 231-237.
6. Crawford, G. B., Meera Agar, M., Quinn, S. J., et al. (2013). Pharmaco-vigilance in hospice/palliative care: Net effect of haloperidol for delirium. Journal of Palliative Medicine, 16(11), 1335-1341.
7. Fernandez, F. & Levy, J. K. (1993). The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus: Case reports. General Hospital Psychiatry, 15(1), 31-35.
8. Fleischhacker, W. W., Miller, C. H., Schett, P., et al. (1991). The Hillside Akathisia Scale: A reliability comparison of the English and German versions. Psychopharmacology, 105(1), 141-144.
9. Frazier, J. A., McClellan, J, Findling, R. L., et al. (2007). Treatment of early-onset schizophrenia spectrum disorders (TEOSS): Demographic and clinical characteristics. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 979-988.
10. Friedman, J. I., Soleimani, L., McGonigle, D. P., et al. (2014). Pharmacological treatments of non-substancewithdrawal delirium: A systematic review of prospective trials. The American Journal of Psychiatry, 171(2), 151-159.
11. Gogtay, N. & Rapoport, J. (2008). Clozapine use in children and adolescents. Expert Opinion on Pharmacotherapy, 9(3), 459-465.
12. Gilchrist, N. A., Asoh, I. & Greenberg, B. (2012). Atypical antipsychotics for the treatment of ICU delirium. Journal of Intensive Care Medicine, 27(6), 354-361.
13. Girard, T. D., Pandharipande, P. P., Carson, S. S., et al. (2010). Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial. Critical Care Medicine, 38(2), 428-437.
14. Han, C. S. &Kim, Y. K. (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics, 45(4), 297-301.
15. Hatta, K., Kishi, Y., Wada, K., et al. (2014). Antipsychotics for delirium in the general hospital setting in 2453 consecutive inpatients: A prospective observational study. International Journal of Geriatric Psychiatry, 29(3), 253-262.
16. Jung Jin, K., Hyun Kook, L., Chi Un, P., et al. (2009). Comparison of intramuscular olanzapine and haloperidol for the treatment of delirium. European Psychiatry, 24, S1006.
17. Jung, J. S., Lee, H. J., Cho, C. H., et al. (2014). Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphism in schizophrenia. Chronobiology International, 31(7), 838-844.
18. Kalisvaart, K. J., de Jonghe, J. F., Bogaards, M. J., et al. (2005). Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: A randomized placebo-controlled study. Journal of the American Geriatrics Society, 53(10), 1658-1666.
19. Kawanishi, C., Onishi, H., Kato, D., et al. (2007). Unexpectedly high prevalence of akathisia in cancer patients. Palliative & Supportive Care, 5(4), 351-354.
20. Kim, J. H., Kim, Y. B., Lee, S. Y., et al. (2011). Antipsychoticassociated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: A high-resolution PETstudy with [11C]raclopride. Journal of Clinical Psychopharmacology, 31(4), 507-511.
21. Kim, J. J., Lim, H. K., Pae, C. U., et al. (2008). Comparison of intramuscular olanzapine and haloperidol for the treatment of delirium. European Neuropsychopharmacology, 18(S4), S424-S425.
22. Kim, S. W., Yoo, J. A., Lee, S. Y., et al. (2010). Risperidone versus olanzapine for the treatment of delirium. Human Psychopharmacology, 25(4), 298-302.
23. Kumar, R. & Sachdev, P. (2009). Akathisia and secondgeneration antipsychotic drugs. Current Opinion in Psychiatry, 22(3), 293-299.
24. Lieberman, J. A. & Stroup, T. S. (2011). The NIMH-CATIE schizophrenia study: What did we learn? The American Journal of Psychiatry, 168(8), 770-775.
25. Lonergan, E., Britton, A. M. & Luxenberg, J. (2007). Antipsychotics for delirium. The Cochrane Database of Systematic Reviews, (2), CD005594.
26. Loonen, A. J. M. & Stahl, S. M. (2011). The mechanism of drug-induced akathisia. CNS Spectrums, 16(1), 7-10.
27. Maneeton, B., Maneeton, N., Srisurapanont, M., et al. (2013). Quetiapine versus haloperidol in the treatment of delirium: A double-blind, randomized, controlled trial. Drug Design, Development and Therapy, 7, 657-667.
28. Menza, M. A., Murray, G. B., Holmes, V. F., et al. (1988). Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: Intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart & Lung, 17(3), 238-241.
29. Miyaji, S., Yamamoto, K., Hoshino, S., et al. (2007). Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients. Psychiatry and Clinical Neurosciences, 61(3), 275-282.
30. Ossowska, K. (2002). Neuronal basis of neurolepticinduced extrapyramidal side effects. Polish Journal of Pharmacology, 54(4), 299-312.
31. Page, V. J., Ely, E. W., Gates, S., et al. (2013). Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): A randomised, double-blind, placebo-controlled trial. The Lancet, Respiratory Medicine, 1(7), 515-523.
32. Pintor, L., Fuente, E., Bailles, E., et al. (2009). Study on the efficacy and tolerability of amisulpride in medical/surgical inpatients with delirium admitted to a general hospital. European Psychiatry, 24(7), 450-455.
33. Sachdev, P. (1994). A rating scale for acute drug-induced akathisia: Development, reliability, and validity. Biological Psychiatry, 35(4), 263-71.
34. Sachdev, P. (1995). Akathisia and restless legs. Cambridge: Cambridge University Press.
35. Sachdev, P. & Loneragan, C. (1991) The present status of akathisia. The Journal of Nervous and Mental Disease, 179(7), 381-391.
36. Seneff, M. G. &Mathews, R. A. (1995). Use of haloperidol infusions to control delirium in critically ill adults. The Annals of Pharmacotherapy, 29(7-8), 690-693.
37. Takeuchi, T., Furuta, K., Hirasawa, T., et al. (2007). Perospirone in the treatment of patients with delirium. Psychiatry and Clinical Neurosciences, 61(1), 67-70.
38. Wada, M., Ito, H., Wada, M., et al. (2011). Drug-induced akathisia as a cause of distress in spouse caregivers of cancer patients. Palliative & Supportive Care, 9(2), 209-212.
39. White, C., McCann, M. A. & Jackson, N. (2007). First do no harm.. Terminal restlessness or drug-induced delirium. Journal of Palliative Medicine, 10(2), 345-351.
40. Yoo, J. A., Kim, S. W., Bae, K. Y., et al. (2011). Risperidone versus olanzapine for the treatment of delirium. European Neuropsychopharmacology, 21, S493.
41. Yoon, H. K., Kim, Y. K., Han, C., et al. (2011). Paliperidone in the treatment of delirium: Results of a prospective openlabel pilot trial. Acta Neuropsychiatrica, 23(4), 179.